Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-10-12 Sale |
2022-10-14 4:32 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
9,000 | $15.91 | $143,194 | 1,171,856 (Indirect Direct) |
View |
| 2022-09-21 Sale |
2022-09-23 6:08 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
8,000 | $16.31 | $130,475 | 1,180,856 (Indirect Direct) |
View |
| 2022-09-14 Sale |
2022-09-16 4:28 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
9,000 | $16.01 | $144,090 | 1,188,856 (Indirect Direct) |
View |
| 2022-08-17 Sale |
2022-08-19 4:49 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
8,000 | $16.59 | $132,692 | 1,197,856 (Indirect Direct) |
View |
| 2021-12-01 Sale |
2021-12-03 6:55 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
5,833 | $24.72 | $144,167 | 1,205,856 (Indirect Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 6:55 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
5,833 | $27.82 | $162,284 | 1,211,689 (Indirect Direct) |
View |
| 2021-10-12 Sale |
2021-10-14 4:44 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
5,531 | $26.3 | $145,448 | 1,217,522 (Indirect Direct) |
View |
| 2021-10-08 Sale |
2021-10-12 6:43 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
302 | $25.02 | $7,555 | 1,223,053 (Indirect Direct) |
View |
| 2021-09-01 Sale |
2021-09-03 5:51 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
5,833 | $25.25 | $147,301 | 1,223,355 (Indirect Direct) |
View |
| 2021-08-10 Sale |
2021-08-12 5:26 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
2,020 | $25.07 | $50,636 | 1,229,188 (Indirect Direct) |
View |
| 2021-08-06 Sale |
2021-08-10 4:53 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
2,443 | $25.01 | $61,088 | 1,231,208 (Indirect Direct) |
View |
| 2021-08-05 Sale |
2021-08-06 4:14 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
1,370 | $25 | $34,250 | 1,233,651 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-09 Option Award |
2022-03-11 4:19 pm |
N/A 2032-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
199,264 | $0 | 199,264 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-08 4:53 pm |
N/A 2031-01-06 |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
204,998 | $0 | 204,998 (Direct) |
View |
| 2020-10-20 Conversion |
2020-10-20 7:53 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO 10% Owner |
23,325 | $0 | 1,235,021 (Indirect) |
View |
Ownership |
2020-10-15 8:07 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO 10% Owner |
0 | $0 | 2,025,647 (Indirect) |
View |